Everlywell has launched Eva, an AI-powered platform that converts biomarker data into personalized health insights and care coordination.
Eva consists of three components: Eva Engage provides automated personalized health communications, Eva Care creates treatment pathways and connects users with Everlywell’s provider network, and Eva Support handles customer service inquiries including product questions and account management.
“We defined accessible, simple lab testing over the past decade—delivering health insights to 60 million Americans—and now we’re deploying the intelligence layer that healthcare has been missing,” said Julia Cheek, founder and CEO of Everlywell. “This is proactive, personalized care powered by AI and grounded in clinical rigor. We’re not replacing human insight. We’re using AI-powered technology to scale it.”
The platform is integrated across Everlywell’s existing services. Consumer engagement rates have more than doubled with Eva Support, according to the company. Everlywell plans to expand Eva’s capabilities later this year to include clinical charting and documentation for clinicians.
According to the company, Everlywell delivers care to nearly 100 enterprise partners and has provided health insights to 60 million people. It works with four of the five largest health plans in the United States, covering 170 million insured lives.
